Alzheimer's disease(AD) is a neurodegenerative disorder characterized by the presence of extracellular amyloid deposits, consisting largely of A beta peptide and the presence of intraneuronal aggregates of neurofibillary tangles formed by tau. Development of cerebrospinal fluid (CSF) biomarkers has become a rapidly growing research field, considering the need for diagnostic tools for AD, thus allowing therapeutic compounds to have the greatest potential for being effective. We have focused oil the relationships between critical biomarkers Such as tau and A beta in the CSF and the cognitive impairment of patients, as assessed by a battery of neuropsychological tests derived from CDR and CERAD, of value in the evaluation of AD patients. As pa...
Reported levels of amyloid-beta and tau in human cerebrospinal fluid (CSF) were evaluated to discove...
Introduction: Biomarkers that will reliably predict the onset of Alzheimer’s disease (AD) are urgent...
Aims Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especiall...
Alzheimer's disease(AD) is a neurodegenerative disorder characterized by the presence of extracellul...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the presence of extracellu...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
Cerebrospinal fluid (CSF) samples from 21 patients with a clinical diagnosis of Alzheimer's disease ...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
AIMS: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especia...
Major efforts are under way to define reliable biomarkers of Alzheimer’s disease. Highly significant...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
Aims Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especiall...
Reported levels of amyloid-beta and tau in human cerebrospinal fluid (CSF) were evaluated to discove...
Introduction: Biomarkers that will reliably predict the onset of Alzheimer’s disease (AD) are urgent...
Aims Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especiall...
Alzheimer's disease(AD) is a neurodegenerative disorder characterized by the presence of extracellul...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the presence of extracellu...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
Cerebrospinal fluid (CSF) samples from 21 patients with a clinical diagnosis of Alzheimer's disease ...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
AIMS: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especia...
Major efforts are under way to define reliable biomarkers of Alzheimer’s disease. Highly significant...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
Aims Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especiall...
Reported levels of amyloid-beta and tau in human cerebrospinal fluid (CSF) were evaluated to discove...
Introduction: Biomarkers that will reliably predict the onset of Alzheimer’s disease (AD) are urgent...
Aims Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especiall...